This invention relates to the field of
biomedical technology, specifically to a topical composition for improving
acne and its application. The topical composition is made from pharmaceutical raw materials including a first component, a second component, and a third component. The first component comprises 25-35 parts of *
Ampelopsis japonica*, 25-35 parts of hawthorn, 25-35 parts of *
Salvia miltiorrhiza*, 13-17 parts of
gardenia, and 8-12 parts of *
Bletilla striata*. The second component comprises 25-35 parts of mother-of-pearl, 13-17 parts of
tribulus terrestris, and 8-12 parts of safflower. The third component comprises 13-17 parts of raw rhubarb, 8-12 parts of gallnut, 8-12 parts of turmeric, 3-7 parts of *
Ganoderma lucidum*, and 3-7 parts of
asparagus. This invention also provides a topical composition consisting of the first, second, or third component alone. The topical composition of this invention has dual effects of inhibiting *
Propionibacterium acnes* and anti-inflammatory properties, and can be further prepared into
cosmetics or pharmaceuticals for the prevention, relief, and treatment of various types of
acne and the improvement of
acne scars. Clinical trials have shown significant effects, high safety, and promising application prospects.